{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T19:30:39Z","timestamp":1777923039938,"version":"3.51.4"},"reference-count":38,"publisher":"SAGE Publications","issue":"12","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Microbial Drug Resistance"],"published-print":{"date-parts":[[2020,12,1]]},"abstract":"<jats:sec>\n                    <jats:title>Purpose:<\/jats:title>\n                    <jats:p>Antibiotics are not the recommended treatment for uncomplicated influenza or nontyphoidal salmonella infections, whereas they are for current pertussis infection. We investigated adherence to these recommendations in a population of older community-dwelling adults.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Population-based prospective cohort study of Australian adults 45 years of age and older followed by record-linkage to laboratory-confirmed influenza, pertussis, and nontyphoidal salmonella notifications, hospitalization records, and antibiotic dispensing data from January 1, 2009 to December 31, 2015. Proportions of those with infections who were prescribed antibiotics were estimated, and characteristics associated with antibiotic prescribing were examined.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>There were 1,056 influenza, 151 pertussis, and 334 nontyphoidal salmonella cases in the cohort eligible for analysis. Antibiotics were dispensed in 56.2% (594\/1,056) of influenza, 78.8% (119\/151) of pertussis, and 39.5% (132\/334) of nontyphoidal salmonella cases within the \u00b110-day window around the infection onset date. The likelihood of antibiotic dispensing did not differ according to most participant characteristics examined, including whether cases had an associated hospitalization, their age, and recorded comorbidities. Macrolides were the predominant class of antibiotics dispensed for pertussis (79%), whereas both beta-lactams (36.3%) and macrolides (35.4%) were used for cases of influenza. There was no dominant antibiotic class dispensed among those with nontyphoidal salmonella.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Given concerns regarding increasing antibiotic resistance, the high proportion of adults with influenza and nontyphoidal salmonella cases dispensed antibiotics indicate the need for further strengthening of antimicrobial stewardship by raising education and awareness of guidelines for managing these infections.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1089\/mdr.2020.0017","type":"journal-article","created":{"date-parts":[[2020,4,21]],"date-time":"2020-04-21T17:37:31Z","timestamp":1587490651000},"page":"1482-1490","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":4,"title":["Antibiotic Use Associated with Confirmed Influenza, Pertussis, and Nontyphoidal Salmonella Infections"],"prefix":"10.1177","volume":"26","author":[{"given":"Wen-Qiang","family":"He","sequence":"first","affiliation":[{"name":"School of Public Health and Community Medicine, UNSW Sydney, Sydney, Australia."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martyn D.","family":"Kirk","sequence":"additional","affiliation":[{"name":"National Center for Epidemiology and Population Health, Research School of Population Health, Australian National University, Canberra, Australia."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vitali","family":"Sintchenko","sequence":"additional","affiliation":[{"name":"Center for Infectious Disease and Microbiology-Public Health, Westmead Hospital, Sydney, Australia."},{"name":"Marie Bashir Institute for Infectious Diseases and Biosecurity, Sydney Medical School, The University of Sydney, Sydney, Australia."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John J.","family":"Hall","sequence":"additional","affiliation":[{"name":"School of Public Health and Community Medicine, UNSW Sydney, Sydney, Australia."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bette","family":"Liu","sequence":"additional","affiliation":[{"name":"School of Public Health and Community Medicine, UNSW Sydney, Sydney, Australia."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2020,12,3]]},"reference":[{"key":"e_1_3_5_2_2","first-page":"413","article-title":"How best to estimate the global burden of pertussis? Lancet","volume":"3","author":"Crowcroft N.S.","year":"2003","unstructured":"Crowcroft N.S., , Stein C., , Duclos P., , and Birmingham M.. 2003. How best to estimate the global burden of pertussis? Lancet. Infect. Dis. 3:413\u2013418.","journal-title":"Infect. Dis"},{"key":"e_1_3_5_3_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cis627"},{"key":"e_1_3_5_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(18)30496-X"},{"key":"e_1_3_5_5_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001921"},{"key":"e_1_3_5_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2017.04.012"},{"key":"e_1_3_5_7_2","unstructured":"Immunization vaccines and bilogicals-pertussis. Available at www.who.int\/immunization\/monitoring_surveillance\/burden\/vpd\/surveillance_type\/passive\/pertussis\/en Accessed March20 2019."},{"key":"e_1_3_5_8_2","unstructured":"Acute infectious diarrhoea-Salmonella enteritis. Available at https:\/\/tgldcdp.tg.org.au\/viewTopic?topicfile=acute-gastroenteritis&guidelineName=Antibiotic#toc_d1e1043 Accessed April4 2019."},{"key":"e_1_3_5_9_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1997.03550110039033"},{"key":"e_1_3_5_10_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.286.10.1181"},{"key":"e_1_3_5_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2004.03.021"},{"key":"e_1_3_5_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2008.09.026"},{"key":"e_1_3_5_13_2","doi-asserted-by":"publisher","DOI":"10.1038\/ng.3281"},{"key":"e_1_3_5_14_2","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.00105-18"},{"key":"e_1_3_5_15_2","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dym184"},{"key":"e_1_3_5_16_2","unstructured":"Public Health Act. 2010. No 127. Available at www.legislation.nsw.gov.au\/#\/view\/act\/2010\/127 Accessed December4 2018."},{"key":"e_1_3_5_17_2","unstructured":"Influenza case definition. Available at www.health.gov.au\/internet\/main\/publishing.nsf\/Content\/cda-surveil-nndss-casedefs-cd_flu.htm Accessed December4 2018."},{"key":"e_1_3_5_18_2","unstructured":"Salmonellosis case definition. Available at www.health.gov.au\/internet\/main\/publishing.nsf\/Content\/cda-surveil-nndss-casedefs-cd_salmon.htm Accessed December4 2018."},{"key":"e_1_3_5_19_2","unstructured":"Pertussis case definition. Available at www.health.gov.au\/internet\/main\/publishing.nsf\/Content\/cda-surveil-nndss-casedefs-cd_pertus.htm Accessed December4 2018."},{"key":"e_1_3_5_20_2","doi-asserted-by":"crossref","first-page":"e0168618","DOI":"10.1371\/journal.pone.0168618","article-title":"Use of proton pump inhibitors and the risk of hospitalization for infectious gastroenteritis","volume":"11","author":"Liu B.","year":"2016","unstructured":"Chen. Y., Liu B., , Glass K., , Du W., , Banks E., , and Kirk M.. 2016. Use of proton pump inhibitors and the risk of hospitalization for infectious gastroenteritis. PLoS One, 11:e0168618.","journal-title":"PLoS One"},{"key":"e_1_3_5_21_2","first-page":"Vienna","article-title":"R: A Language and Environment for Statistical Computing","author":"Team RC","year":"2017","unstructured":"Team RC. 2017. R: A Language and Environment for Statistical Computing. R Foundation for Statistical, Computing, Vienna, Austria.","journal-title":"R Foundation for Statistical"},{"key":"e_1_3_5_22_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.289.6.719"},{"key":"e_1_3_5_23_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.4151"},{"key":"e_1_3_5_24_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2018.0243"},{"key":"e_1_3_5_25_2","doi-asserted-by":"publisher","DOI":"10.1002\/pds.1067"},{"key":"e_1_3_5_26_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/civ076"},{"key":"e_1_3_5_27_2","doi-asserted-by":"crossref","first-page":"e0221480","DOI":"10.1371\/journal.pone.0221480","article-title":"Socio-demographic and health service factors associated with antibiotic dispensing in older Australian adults","volume":"14","author":"Chen Y.","year":"2019","unstructured":"Chen Y., , Kirk M.D., , Stuart R., , Cheng A.C., , Pearson S.-A., , Hayen A., , Banks E., , and Liu B.. 2019. Socio-demographic and health service factors associated with antibiotic dispensing in older Australian adults. PLoS One, 14:e0221480.","journal-title":"PLoS One"},{"key":"e_1_3_5_28_2","first-page":"236","article-title":"Appropriateness of antibiotic use in enteric fever inpatients in Tertiary Care Hospitals in Western Nepal: A Cross-Sectional Study","volume":"3","author":"Alam K.","year":"2013","unstructured":"Alam K., , Mishra P., , and Angsulee N.. 2013. Appropriateness of antibiotic use in enteric fever inpatients in Tertiary Care Hospitals in Western Nepal: A Cross-Sectional Study. NJE, 3:236\u2013242.","journal-title":"NJE"},{"key":"e_1_3_5_29_2","unstructured":"Theraputic Guidelines: Pertussis. Available at tgldcdp.tg.org.au\/viewTopic?topicfile=pertussis&guidelineName=Antibiotic#toc_d1e110 Accessed December4 2018."},{"key":"e_1_3_5_30_2","unstructured":"Trends in consultation rates in general practice\u20141995\u20132009. Available at https:\/\/digital.nhs.uk\/data-and-information\/publications\/statistical\/trends-in-consultation-rates-in-general-practice\/trends-in-consultation-rates-in-general-practice\u20141995\u20132009 Accessed June6 2019."},{"key":"e_1_3_5_31_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2017-020203"},{"key":"e_1_3_5_32_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkw054"},{"key":"e_1_3_5_33_2","article-title":"Antibiotics for treating salmonella gut infections","author":"Sirinavin S.","year":"2000","unstructured":"Sirinavin S., , and Garner P.. 2000. Antibiotics for treating salmonella gut infections. Cochrane Database Syst. Rev. CD001167.","journal-title":"Cochrane Database Syst. Rev"},{"key":"e_1_3_5_34_2","first-page":"CD001167","article-title":"Antimicrobials for treating symptomatic non-typhoidal Salmonella infection","volume":"11","author":"Onwuezobe I.A.","year":"2012","unstructured":"Onwuezobe I.A., , Oshun P.O., , and Odigwe C.C.. 2012. Antimicrobials for treating symptomatic non-typhoidal Salmonella infection. Cochrane Database Syst. Rev. 11:CD001167.","journal-title":"Cochrane Database Syst. Rev"},{"key":"e_1_3_5_35_2","doi-asserted-by":"publisher","DOI":"10.5694\/mja16.01042"},{"key":"e_1_3_5_36_2","doi-asserted-by":"publisher","DOI":"10.5694\/mja17.00574"},{"key":"e_1_3_5_37_2","doi-asserted-by":"publisher","DOI":"10.1186\/s40545-018-0145-y"},{"key":"e_1_3_5_38_2","doi-asserted-by":"publisher","DOI":"10.1177\/0300060517740813"},{"key":"e_1_3_5_39_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2012.194139"}],"container-title":["Microbial Drug Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1089\/mdr.2020.0017","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/mdr.2020.0017","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/mdr.2020.0017","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T20:37:24Z","timestamp":1777667844000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1089\/mdr.2020.0017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,1]]},"references-count":38,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2020,12,1]]}},"alternative-id":["10.1089\/mdr.2020.0017"],"URL":"https:\/\/doi.org\/10.1089\/mdr.2020.0017","relation":{},"ISSN":["1076-6294","1931-8448"],"issn-type":[{"value":"1076-6294","type":"print"},{"value":"1931-8448","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12,1]]}}}